Literature DB >> 3002806

Interaction of pitrazepin with the GABA/benzodiazepine receptor complex and with glycine receptors.

C Braestrup, M Nielsen.   

Abstract

Pitrazepin (3-(piperazinyl-1)-9H-dibenz(c,f)triazolo(4,5-a)azepin) is a new GABAA receptor antagonist reported to antagonize electrophysiological effects of GABA. We have investigated in some detail the interaction of pitrazepin with the GABA/benzodiazepine receptor chloride channel complex. Pitrazepin was found to be a competitive inhibitor of the GABAA receptor which is coupled to [3H]diazepam and [35S]TBPS binding sites; the KI value obtained by Schild analyses was 80 nM. Although pitrazepin interacted weakly with BZ receptors the compound did not affect the chloride gating mechanism (labelled with [35S]TBPS or [3H]avermectin B1a). Further, pitrazepin was a non-selective GABA antagonist since glycine receptors, labelled with [3H]strychnine, were affected at low concentrations (the KI values in rat brain-stem were 71-110 nM).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002806     DOI: 10.1016/0014-2999(85)90669-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Antagonistic action of pitrazepin on human and rat GABA(A) receptors.

Authors:  A Demuro; A Martinez-Torres; W Francesconi; R Miledi
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Electrophysiological study of SR 42641, a novel aminopyridazine derivative of GABA: antagonist properties and receptor selectivity of GABAA versus GABAB responses.

Authors:  M Desarmenien; E Desaulles; P Feltz; M Hamann
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.